Speak directly to the analyst to clarify any post sales queries you may have.
The connected medical devices market is transforming the healthcare landscape, equipping decision-makers with real-time data and analytics to support advanced patient care and streamlined clinical workflows. As organizations move toward integrated digital health ecosystems, the sector offers actionable avenues for operational improvement, competitive differentiation, and future-ready resilience.
Market Snapshot: Connected Medical Devices Market Size and Growth Outlook
The connected medical devices market continues its notable expansion, advancing from USD 54.75 billion in 2024 to USD 67.26 billion in 2025. It is projected to reach USD 291.37 billion by 2032, reflecting a compound annual growth rate (CAGR) of 23.24%. This trajectory underscores the pivotal role of digital integration in health systems, where real-time data monitoring, remote care delivery, and device interoperability are redefining care models and enabling sustained progress toward more adaptive healthcare strategies.
Scope & Segmentation: Comprehensive View Across the Connected Medical Devices Landscape
- Product Types: Diagnostic devices (including imaging systems, point-of-care test kits, and ultrasound devices), monitoring devices (such as ECG units, glucose meters, and vital signs monitors), surgical devices (electrosurgical, endoscopic, and robotic surgical systems), therapeutic devices (encompassing dialysis, infusion, and ventilator systems), and wearable devices (ranging from fitness trackers to smart watches).
- Applications: Drug delivery solutions (covering infusion, inhalation, and injection methods), imaging technologies (including CT, MRI, ultrasound, and X-ray), patient monitoring (across ambulatory, critical care, and remote settings), rehabilitation (such as neurorehabilitation and therapies for occupational and physical health), surgical assistance (including navigation and robotics), and telehealth (supporting remote diagnosis, monitoring, and video consultation).
- End Users: Ambulatory care centers, clinics, diagnostic centers, home care environments for elderly or post-operative patients, and both public and private hospitals.
- Connectivity Technologies: Bluetooth and BLE, cellular networks (2G/3G/4G/5G), NFC, Wi-Fi standards (802.11ac, 802.11n), and Zigbee, enabling secure, high-speed communication across healthcare devices and platforms.
- Distribution Channels: Offline traditional networks and online platforms are shaping accessibility and influencing market penetration strategies for device manufacturers and service providers.
- Regional Coverage: Americas (with a focus on North America and Latin America), Europe, Middle East & Africa (including key markets like the United Kingdom, Germany, France, Russia, Italy, and select Middle Eastern countries), and Asia-Pacific (notably China, India, Japan, Australia, and rapidly advancing Southeast Asian territories).
- Company Coverage: Comprehensive analysis includes Koninklijke Philips N.V., General Electric Company, Medtronic plc, Siemens Healthineers AG, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Baxter International Inc., ResMed Inc., and Dexcom, Inc.
Key Takeaways: Strategic Insights for the Connected Medical Devices Market
- The integration of artificial intelligence and machine learning within connected medical devices catalyzes proactive patient care and more informed diagnostics across clinical environments.
- Interoperability and cybersecurity remain top concerns, as seamless device integration and data protection shape procurement and partnership decisions for stakeholders globally.
- Regional specificities in regulatory frameworks, public and private funding, and digital readiness demand tailored go-to-market and service models to capture growth effectively.
- The rise of service-based and subscription models is diversifying revenue pools, while value-added analytics drive stronger engagement among healthcare providers seeking operational and clinical insights.
- Market leaders leverage technology-driven collaborations, robust IP strategies, and focused investment in secure cloud analytics to strengthen their competitive positioning in an evolving digital health ecosystem.
- Innovation driven by recent healthcare challenges, such as the COVID-19 pandemic, has permanently shifted how remote monitoring and telehealth applications are prioritized and adopted across settings.
Tariff Impact: Navigating Supply Chain and Cost Pressures
The 2025 implementation of U.S. tariffs on critical electronic and medical device components prompted manufacturers to reassess sourcing frameworks and cost efficiency. Companies have evaluated nearshoring and adopted domestic supplier partnerships, while pursuing tariff exemptions for essential supplies. Operational cost increases have led healthcare organizations to transition toward modular, flexible device platforms, and incentivized local manufacturing strategies. These shifts highlight an urgent need for robust supply chain diversification and proactive risk management amid ongoing geopolitical pressures.
Methodology & Data Sources
This report applies a rigorous methodology, combining executive interviews, expert workshops, and practitioner roundtables, further supported by analysis of industry reports, regulatory filings, and government health agency data. All findings are cross-validated and peer reviewed by subject matter experts for reliability and accuracy.
Why This Report Matters
- Obtain an in-depth understanding of shifting trends and regulations in connected medical devices to support strategic planning and investment.
- Pinpoint and evaluate critical opportunities for growth, innovation, and market entry, factoring in technology enablement and evolving channel dynamics.
- Support executive teams with actionable analysis to optimize digital transformation efforts and expand global healthcare market access.
Conclusion
Digital integration and strategic collaboration are advancing the connected medical devices market toward more unified, data-driven care. Organizations that emphasize interoperability, resilient supply chains, and robust data protection will be positioned to achieve long-term strategic value in this landscape.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples
LOADING...
Companies Mentioned
The key companies profiled in this Connected Medical Devices market report include:- Koninklijke Philips N.V.
- General Electric Company
- Medtronic plc
- Siemens Healthineers AG
- Johnson & Johnson
- Abbott Laboratories
- Boston Scientific Corporation
- Baxter International Inc.
- ResMed Inc.
- Dexcom, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 189 |
Published | October 2025 |
Forecast Period | 2025 - 2032 |
Estimated Market Value ( USD | $ 67.26 Billion |
Forecasted Market Value ( USD | $ 291.37 Billion |
Compound Annual Growth Rate | 23.2% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |